LaFleur & Godfrey LLC Purchases 7,133 Shares of Stryker Corporation $SYK

LaFleur & Godfrey LLC boosted its position in Stryker Corporation (NYSE:SYK) by 9.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 82,899 shares of the medical technology company’s stock after acquiring an additional 7,133 shares during the quarter. Stryker accounts for about 2.7% of LaFleur & Godfrey LLC’s holdings, making the stock its 9th biggest holding. LaFleur & Godfrey LLC’s holdings in Stryker were worth $22,830,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in SYK. Amundi lifted its holdings in Stryker by 18.3% during the 2nd quarter. Amundi now owns 1,246,353 shares of the medical technology company’s stock worth $392,402,000 after buying an additional 192,447 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of Stryker by 8.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 859,544 shares of the medical technology company’s stock worth $270,642,000 after acquiring an additional 65,333 shares in the last quarter. Veritas Asset Management LLP purchased a new position in shares of Stryker in the 2nd quarter valued at about $168,057,000. Bank of America Corp DE purchased a new position in shares of Stryker in the 2nd quarter valued at about $1,404,284,000. Finally, Rakuten Investment Management Inc. acquired a new stake in shares of Stryker during the 2nd quarter worth about $18,646,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Transactions at Stryker

In other news, insider Debra King sold 826 shares of Stryker stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total value of $277,783.80. Following the transaction, the insider directly owned 6,210 shares of the company’s stock, valued at $2,088,423. The trade was a 11.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Dylan Crotty sold 441 shares of Stryker stock in a transaction on Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the completion of the transaction, the insider directly owned 6,102 shares in the company, valued at $2,005,178.22. The trade was a 6.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 351,267 shares of company stock worth $118,197,701. Insiders own 4.60% of the company’s stock.

Stryker Trading Up 0.8%

NYSE:SYK opened at $303.85 on Thursday. The stock’s 50 day moving average price is $294.14 and its 200 day moving average price is $325.14. The company has a market capitalization of $116.55 billion, a PE ratio of 31.49, a P/E/G ratio of 1.98 and a beta of 0.78. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. Stryker Corporation has a 52-week low of $267.00 and a 52-week high of $389.33.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%. The company had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. During the same quarter in the previous year, the company posted $3.13 earnings per share. The firm’s revenue was up 9.4% compared to the same quarter last year. On average, research analysts anticipate that Stryker Corporation will post 14.93 EPS for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.88 dividend. This represents a $3.52 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s dividend payout ratio is presently 36.48%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on SYK. Wells Fargo & Company decreased their target price on Stryker from $418.00 to $348.00 and set an “overweight” rating for the company in a research note on Wednesday, September 9th. Evercore set a $350.00 price target on shares of Stryker in a research note on Monday, July 6th. BMO Capital Markets reissued an “outperform” rating and set a $317.00 price objective on shares of Stryker in a report on Wednesday, September 9th. Citigroup cut their price objective on shares of Stryker from $399.00 to $360.00 and set a “buy” rating on the stock in a report on Thursday, September 10th. Finally, Barclays upgraded shares of Stryker to a “strong-buy” rating in a research report on Wednesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $369.00.

Stryker Company Profile

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.